Recent clinical guidelines, reports, publications and presentations using OncoSim are listed below. To access model assumptions and data sources, please request an account. For any inquiries, contact firstname.lastname@example.org.
Guidelines and reports
Canadian Task Force on Preventive Health Care guidelines
- Recommendations on screening for colorectal cancer in primary care (March 2016)
- Recommendations on screening for lung cancer (April 2016)
Canadian Cancer Society annual statistics reports
- Canadian Cancer Statistics, 2016; Special topic: HPV associated cancers
- Canadian Cancer Statistics, 2015; Special topic: Predictions of the future burden of cancer in Canada
Alberta STE* Report, Institute of Health Economics
- Low dose computed tomography for the screening of lung cancer in adults (May 2014)
*STE = Social and System Demographics Analysis, Technology Effects and Effectiveness, Economic Analysis
- Evans WK, Wolfson MC, Flanagan WM, Shin J, Goffin J, Miller AB, et al. Canadian Cancer Risk Management Model: Evaluation of cancer control. Internaltion Journal of Technology Assessment in Health Care. 2013 Apr;29(2):131-9.
- Gauvreau CL, Fitzgerald NR, Memon S, Flanagan WM, Nadeau C, Asakawa, K et al. The OncoSim Model: Development and use for better decision-making in Canadian cancer control. Curr Oncol. 2017 Dec; 24 (6); 401-406.
- Evans WK, Wolfson M, Flanagan WM, Shin J, Goffin JR, Asakawa K, et al. The evaluation of cancer control interventions in lung cancer using the Canadian Cancer Risk Management Model. Lung Cancer Manage. 2012 June;1(1):25-33.
- Louie AV, Rodrigues GB, Palma DA, Senan S. Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada. Oncologist. 2014 Aug;19(8):880-5.
- Fitzgerald NR, Flanagan WM, Evans WK, Miller AB. Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals. Scand J Work Environ Health. 2015 Jul;41(4):407-12.
- Flanagan WM, Evans WK, Fitzgerald NR, Goffin JR, Miller AB, Wolfson MC. Performance of the cancer risk management model lung cancer screening module. Health Rep. 2015 May;26(5):11-8.
- Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC.Cost-effectiveness of lung cancer screening in Canada. JAMA Oncol. 2015 Sep;1(6):807-13.
- Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, et al. Implementing low-dose computer tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency and duration. Curr Oncol. 2016 Jun;23(3):e179-87.
- Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, et al. Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness. Lung Cancer. 2016 Nov;101:98-103.
- Coldman AJ, Phillips N, Brisson J, Flanagan W, Wolfson M, Nadeau C, et al. Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada. Curr Oncol. 2015 Apr;22(2):e41-50.
- Coldman AJ, Flanagan WM, Nadeau C, Wolfson MC, Fitzgerald NR, Memon S, et al. Projected Effect of Fecal Immunochemical Test Threshold for Colorectal Cancer Screening on Outcomes and Costs for Canada using the OncoSim Microsimulation Model. J Cancer Policy. 2017 Sept; 13: 38-46.
- Coldman AJ, Pader J, Gauvreau, C, Memon S, Fitzgerald NR, Flanagan WM et al. Simulating Results from Trials of Sigmoidoscopy Screening Using the OncoSim Microsimulation Model. J Cancer Policy. 2018 Mar; 15: 52-58.
Cervical cancer / HPV
- Miller AB, Gribble S, Nadeau C, Asakawa K, Flanagan WM, Wolfson M, et al. Evaluation of the natural history of cancer of the cervix, implications for prevention. The Cancer Risk Management Model (CRMM)—Human papillomavirus and cervical components. Journal of Cancer Policy. 2015 Jun;4:1-6.
- Popadiuk C, Gauvreau CL, Bhavsar M, Nadeau C, Asakawa K, Flanagan WM, et al. Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada. Curr Oncol. 2016 Feb;23(Suppl 1):S56-S63.
- Lacombe J, Gauvreau CL, Memon S, Popadiuk C, Flanagan WM, Nadeau C, et al. Exploring the health outcomes of various pan-Canadian cervical cancer screening programs using microsimulation modeling. Am J Epidemiol. 2016;184(1):78-80.
- Lacombe J, Memon S, Gauvreau C, Popadiuk C, Flanagan W, Nadeau C, et al. Exploring the health outcomes of various pan-Canadian cervical screening programs using microsimulation modelling. Oral presentation at the Canadian Society for Epidemiology and Biostatistics 2016 National Student Conference. Jun 2016.
- Gauvreau C, Memon S, Lacombe J. Health and economic impacts of organized vs. opportunistic lung cancer screening. Webinar presented for Analytic Capacity Building Initiative. Mar 2016.
- Lung cancer screening and smoking cessation: Scenarios for Pan-Canadian Lung Cancer Screening Network. May 2014.
- Colorectal cancer screening: Scenarios for National Colorectal Cancer Screening Network. May 2014.
- Cervical cancer screening scenarios for pan-Canadian Cervical Screening Initiative. June 2014.
- Memon S, Gauvreau C, Lacombe J, Flanagan WM, Goffin JR, Wolfson MW, et al. Comparing the health and economic outcomes of opportunistic lung cancer screening vs. organized lung screening using the Cancer Risk Management Model. Poster presentation for Canadian Centre for Applied Research in Cancer Control. May 2016.
- Fitzgerald N, Goffin J, Miller AB, Memon S, Flanagan W, Evans WK. Annual vs. biennial lung cancer screening using the Cancer Risk Management Model to fill gaps in evidence. May 2014.
- Memon S, Miller AB, Flanagan WM, Nadeau C, Earle C, Fitzgerald N, et al. Comparing the health and economic impacts of two screening strategies for colorectal cancer in Canada using the Cancer Risk Management Model (CRMM). May 2014.
To learn how to use the OncoSim platform, download the OncoSim user guide. This practical resource provides detailed information on the sub-models, as well as examples of applications. You will find out how to understand, analyze, edit and run simulations and scenarios.
To view other model documentation, such as the data dictionary, model assumptions and information on the model structure, please request an account.